GlassScriptPhysician profile
Susan S Wilder
NPI 1447218698
$3,288.36
in general payments reported to CMS, 2019-2025
41 companies · $750 in 2025
The $750 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $271 · 2021: $454 · 2022: $270 · 2023: $626 · 2024: $645 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,021.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $541.41 | 2019-2025 | Ubrelvy, Vraylar, Qulipta |
| Astrazeneca Pharmaceuticals LP | $475.98 | 2020-2025 | Airsupra, Breztri, Farxiga |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $328.89 | 2019-2025 | Xifaxan |
| Novo Nordisk INC | $234.23 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $233.07 | 2020-2025 | Mounjaro, Zepbound, Kisunla |
| Abbott Laboratories | $140.84 | 2021-2025 | Assurity, Tacticath Ablation Catheter, Sensor Enabled, Octrode |
| Novartis Pharmaceuticals Corporation | $134.98 | 2019-2025 | |
| Amgen INC. | $121.99 | 2019-2024 | Evenity, Prolia |
| Pfizer INC. | $117.18 | 2020-2025 | |
| Qol Medical, LLC | $71.10 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $68.86 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $65.03 | 2019-2023 | Trintellix |
| Astellas Pharma US INC | $63.59 | 2025 | Veozah |
| Glaxosmithkline, LLC. | $62.84 | 2019-2024 | Nucala |
| Millicent US INC | $52.91 | 2020 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Wilder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.